The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17

Dirkje Sommeijer, Christos Karapetis, John Zalcberg, Dongsheng Tu, Derek Jonker, John Simes, Niall Tebbutt, Desmond Yip, Timothy Price, Chris O'Callaghan

    Research output: Contribution to journalArticlepeer-review

    9 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Nursing and Health Professions

    Pharmacology, Toxicology and Pharmaceutical Science